379 related articles for article (PubMed ID: 16306156)
21. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
22. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
23. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
24. WHO classification of meningiomas-A single institutional experience.
Salami AA; Okunlola AI; Ajani MA; Onakpoma F
Neurochirurgie; 2021 Apr; 67(2):119-124. PubMed ID: 33144180
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Radiation on Meningioma Volume Change.
Hall JT; Opalak CF; Carr MT; Harris TJ; Broaddus WC
World Neurosurg; 2021 Sep; 153():e141-e146. PubMed ID: 34166829
[TBL] [Abstract][Full Text] [Related]
26. World Health Organization grade II meningiomas.
Champeaux C; Dunn L
Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
[TBL] [Abstract][Full Text] [Related]
27. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
[TBL] [Abstract][Full Text] [Related]
28. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
31. Classification of Meningiomas Based on Their Surgical Removal, World Health Organization Grade, and Cytogenetic Profile: A Treatment Algorithm.
da Silva CE; de Freitas PEP
World Neurosurg; 2017 Sep; 105():289-293. PubMed ID: 28587980
[TBL] [Abstract][Full Text] [Related]
32. [Meningiomas].
Kalamarides M; Goutagny S
Rev Prat; 2006 Oct; 56(16):1792-8. PubMed ID: 17315505
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?
Marcus HJ; Price SJ; Wilby M; Santarius T; Kirollos RW
Br J Neurosurg; 2008 Aug; 22(4):520-8. PubMed ID: 18803079
[TBL] [Abstract][Full Text] [Related]
34. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas.
El-Khatib M; El Majdoub F; Hoevels M; Kocher M; Müller RP; Steiger HJ; Sturm V; Maarouf M
Acta Neurochir (Wien); 2011 Sep; 153(9):1761-7. PubMed ID: 21706274
[TBL] [Abstract][Full Text] [Related]
36. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
38. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
[TBL] [Abstract][Full Text] [Related]
39. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma.
Lee JJB; Lee J; Yoon HI; Kim SH; Cho J; Lee KS; Chang JH; Suh CO
J Neurooncol; 2019 Sep; 144(2):333-341. PubMed ID: 31278690
[TBL] [Abstract][Full Text] [Related]
40. Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.
Peyre M; Zanello M; Mokhtari K; Boch AL; Capelle L; Carpentier A; Clemenceau S; Karachi C; Navarro S; Nouet A; Reina V; Valery CA; Sanson M; Cornu P; Kalamarides M
J Neurooncol; 2015 May; 123(1):151-60. PubMed ID: 25894596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
